Market News & Trends
Elite Pharmaceuticals Announces Positive Top-Line Results
Elite Pharmaceuticals, Inc. recently announced positive top-line results from the Phase III pivotal trial of its lead opioid abuse-deterrent candidate, ELI-200, for the treatment of…
Honeywell to Acquire Research Chemicals Business From Sigma-Aldrich
Honeywell recently announced it has signed a definitive agreement to acquire the Seelze, Germany-based laboratory research chemicals business from Sigma-Aldrich for approximately 105 million euro.…
EMD Millipore to Provide Provantage End-to-End Solution for Development & Manufacture of Biosimilars Under Strategic Alliance
EMD Millipore recently announced it has entered into a strategic alliance with Turgut Ilaç, a leading biosimilars company based in Turkey and will provide their…
CytoDyn Injects First Patient in Its Current Phase III Study
CytoDyn Inc. recently announced that the first patient in its Phase III clinical trial has been injected with PRO 140, the company's monoclonal antibody for…
BioXcel Initiates Strategic Big Data Partnership With Pronutria
BioXcel Corporation recently announced the initiation of a strategic big data collaboration with Pronutria Biosciences to identify diseases characterized by high unmet need for therapies…
Opsonix is Launched to Develop Pathogen-Extracting Therapy
Opsonix, Inc. recently announced the company’s launch with an $8-million Series A financing to develop a pathogen-extracting therapy designed to remove infectious pathogens and toxins…
Codexis Earns $6.5-Million Milestone From GSK
Codexis, Inc. recently announced it successfully completed Wave 2 of the transfer of its proprietary CodeEvolver protein engineering platform technology to GlaxoSmithKline (GSK) in the…
Emisphere Signs Lucrative License Agreement With Novo Nordisk
Emisphere Technologies, Inc. recently announced it has entered into a Development and License Agreement with Novo Nordisk A/S to develop and commercialize oral formulations of…
West Launches New Ready-to-Use/Validated Components
West Pharmaceutical Services, Inc. recently launched Daikyo RUV (ready-to-use/validated) components at CPhI Worldwide/InnoPack Europe 2015 in Madrid, Spain. In addition, West is showcasing a range…
Ajinomoto Althea Expands Manufacturing Capabilities to ADC Fill Finish & Bioconjugation
Ajinomoto Althea, Inc. recently announced it is expanding its existing biological drug product manufacturing operations to include highly active materials such as Antibody Drug Conjugates…